RAD50 function of Saccharomyces cerevlslae Is required during vegetative growth for recombinatlonal repair of DNA double strand breaks, and during melosls for Initiation of melotlc recombination and formation of synaptonemal complex. RAD50 encodes a 153 kDa polypeptlde which Includes an amlno-termlnal ATP binding domain essential for function and two long heptad repeat regions. We show below that RAD50 protein purified from yeast exhibits ATP-dependent binding to double stranded DNA. Physical properties of the purified protein are also described. Models for RAD50 function In vivo are discussed.
INTRODUCTION
The RAD50 gene of S.cerevisiae is required during vegetative growth for recombinational repair of double strand breaks (DSBs) (1, 2, 3) and for efficient mating type switching, a directed recombination event initiated by a programmed site-specific double strand break (A.McKee and N.K. unpublished observations).
During meiosis, RAD50 is required for initiation of meiotic recombination (4-6), a process which also involves double strand breaks (6) (7) (8) . In addition, RAD50 function is required for formation of synaptonemal complex (SC) between homologous chromosomes during meiotic prophase (5, B.Byers, cited in 9, 10). The role of RAD50 function in the latter process may be indirect, since SC formation may require a prior recombinational interaction between homologues (5, 11-13); however, a direct role for RAD50 function in SC formation is not excluded.
The polypeptide predicted for RAD50 protein is 153 kDa (1312 amino acids). The protein contains an amino-terminal ATP binding domain (14) . Mutations that alter critical conserved amino acids of the ATP binding site confer a null phenotype, and a specific class of non-null mutations which are primarily defective in meiosis (rad50S) alter non-conserved residues within the ATP binding domain (5) . The remainder of the protein includes two long segments of heptad repeat sequence diagnostic of regions capable of forming alpha-helical coiled coils, one of which is of the same length as and exhibits significant amino acid similarity to the S-2 domain of the rabbit myosin heavy chain (14) .
We report here the initial biochemical characterization of RAD50 protein purified from yeast which demonstrates the presence of ATP-dependent DNA binding activity. An updated discussion of possible in vivo roles for RAD50 protein is presented in the Discussion.
MATERIALS AND METHODS

Overproduction and purification of Rad50 protein
A plasmid containing the RAD50 coding sequence fused at the ATG to the PH05 promoter (pNKY2076) (15) was introduced into the protease-defective S.cerevisiae strain BJ2667 (MATa Ieu2 ura3-52 prbl-1122; kindly provided by Elizabeth Jones, Carnegie-Mellon University). A 2 liter culture of such cells was grown to stationary phase in low-phosphate medium at 30°C (16) . Cells were harvested and lysed essentially as described by Worland and Wang (17) . Debris was eliminated by successive centrifugations at 15K rpm for 20 minutes and 5 minutes. The resulting supernatant (= Fraction 0) typically contained 450 mg of protein. Fraction 0 was adjusted to a total protein concentration of 5 mg/ml with buffer I [50 mM Tn--HC1, pH7.7; 1 mM EDTA, pH 8; 1 mM EGTA, pH 8; 10% glycerol 'v/v); 1 mM phenylmethylsulfonyl fluoride; 1 mM /S-mercaptoethanol)] and brought to a KC1 concentration of 0.1 M. Then, polyethyleneimine (Bethesda Research Laboratories) was added from a 10% (v:v) stock solution at pH 7.7 over a 15 minute period to a final concentration of 0.2%. After 15 minutes, the mixture was centrifuged at 8K rpm for 10 minutes. The resulting pellet was washed twice in buffer I containing 0.5M KC1 and supernatants from both washes were combined (= Fraction 1). Fractionation with ammonium sulfate (35%-60%) yielded a pellet that was dissolved in 4ml of gT/200 (10% glycerol, 50mM Tris pH7.7, 2.3mM j3-mercaptoethanol, 200 mM NaCl) to give Fraction 2, which was then fractionated on a Sephacryl S400-HR(Pharmacia) column equilibrated and run in gT/200. Fractions enriched for RAD50 protein were identified on SDS polyacrylamide gels (18) and pooled (= Fraction 3). Fraction 3 was diluted with 10% glycerol, 50 mM Tris, pH 7.7 to a conductivity equal to that of gT/100 (10% glycerol, 50 mM Tris, pH 7.7, 2.3 mM /3-mercaptoethanol, 100 mM NaCl) and then loaded onto a 1 ml phosphocellulose (Whatman) column most DNA remains bound by RAD50 protein ( Figure 2C) . (2) In reactions with biotinylated DNA as substrate, streptavidinagarose precipitation of the DNA results in ATP-dependent coprecipitation of RAD50 protein ( Figure 3 ). Since the fraction of RAD50 protein precipitated by streptavidin in the presence of ATP is the same as the fraction of DNA molecules precipitated, it appears that most or all of the RAD50 protein is bound to DNA. The presence of RAD50 protein in the reaction mixture does not change the fraction of biotinylated DNA precipitated (data not shown). Also, biotinylation of the substrate DNA does not affect the ability of RAD50 protein to bind to it, as measured by immunoprecipitation assays (15) . (3) Highly specific anti-RAD50 antiserum will precipitate DNA in the presence of purified RAD50 protein and ATP; no precipitation is observed in the absence of ATP or with preimmune serum (15) .
Nudeotide dependence of binding to double stranded DNA RAD50-dependent binding to double stranded DNA is not observed in the absence of a nucleoti.de cofactor, is observed in the presence of rATP, dATP, ddATP or ATPyS, and is not observed in the presence of ADP or other nucleoside triphosphates ( Figure 4 ). The affinity of RAD50 protein for ATP is apparently relatively low: an ATP concentration of 2-5 mM was required for optimal filter binding activity (data not shown). High level ATPase activity is not detected under standard reaction conditions (^ 1 molecule of ATP hydrolyzed per molecule of RAD50 protein per minute assuming that all of the protein is active).
Substrate dependence RAD50-dependent DNA binding activity has not yet been characterized in detail. At a gross level, under conditions similar to those used for the binding reactions reported here, binding of RAD50 protein is not sensitive to the sequence or presence of ends on a duplex lambda DNA substrate and is able to bind single stranded M13 DNA (W.R., K.Reilly and N.K., unpublished observations). However, affinities for different substrates have not been examined under conditions that might reveal subde differences (for example, initial binding to ends followed by subsequent binding elsewhere on the substrate molecule). 
Physical properties of RAD50 protein
In the presence of 200mM NaQ, RAD50 protein is an homogeneous asymmetric dimer: Stokes radius -152A; sedimentation coefficient -4.3S; calculated molecular weight 282,000 daltons, or -1.8 times the monomer molecular weight of 153,000; frictional coefficient (calculated for a dimeric species) of 3.4 and axial ratio of slighdy more than 60 (Materials and Mediods). At a lower salt concentration (20mM NaCl), the conformation of RAD50 protein changes to a less asymmetric form: the protein exists as a heterogeneous mixture of species with sedimentation coefficients ranging from 4S to US but exhibiting a much smaller average Stokes radius than observed under higher salt conditions. The properties of these lower ionic strength forms are consistent with their being either dimers or a mixture of dimers and higher order oligomers.
DISCUSSION
Biochemistry of RAD50 protein RAD50 protein binds double stranded DNA in an ATP-dependent fashion. Under the conditions examined thus far, binding is not grossly sensitive to overall DNA sequence composition or to the presence or absence of ends. RAD50 protein appears to bind DNA with reasonable affinity: under standard conditions, most of the RAD50 protein is bound to DNA after 60 minutes at a protein concentration of about 35nM (Figure 3) , and dilution of such protein/DNA complexes does not result in rapid release of bound protein ( Figure 2C ). Although assay-dependent, quantitative differences in RAD50 protein binding to DNA are apparent, the fundamental, qualitative conclusion that purified RAD50 protein binds double stranded DNA in an ATP-dependent manner is clear. These observations are consistent with die possibility that direct contact with DNA is an important feature of RAD50 function. Detailed consideration of the stoichiometry of DNA binding in these initial experiments reveals a number of irregularities which suggest mat RAD50 protein may preferentially load (cooperatively) onto a subset of DNA molecules in the population rather than distributing itself at random (Figures 2 and 3; 15) ; alternatively, oligomerization of Rad50 protein at relatively low salt concentrations may account for these irregularities.
Binding of RAD50 protein to DNA requires an adenosine triphosphate nucleotide. Binding may not require ATP hydrolysis, since ATPyS substitutes effectively for ATP. These observations are consistent with our previous speculation that radSOS mutations, which map in the ATP binding domain of RAD50 protein but not in consensus residues, might affect release of bound RAD50 protein from DNA (14) .
At high ionic strength, RAD50 protein exists as a single asymmetric homodimer. At lower ionic strengths, the physical properties of RAD50 protein change, with the quaternary structure becoming more heterogeneous and less asymmetric. This pattern of changes is intriguingly similar to that of phosphorylated smooth muscle myosin, which changes from an extended 6S monomeric form (two heavy chains and four light chains; Stokes radius 185A) to a folded 10S monomeric species (Stokes radius 125A) and then to a folded dimeric species (27, 28) . Moreover, this myosin transition specifically involves a bend within the S-2 domain of the heavy chain. Perhaps Heptad II of RAD50 protein, which shows significant similarity to the S-2 domain (14), is involved in an analogous transition, with a bend occurring specifically at the hinge region of this domain. The structural and functional significance of the ionic strength transition for RAD50 protein remains to be determined. All of the DNA binding experiments reported above were carried out at intermediate concentrations of NaCl (27-67mM) . In the myosin case, several observations are consistent with the possibility that the observed structural transitions are biologically significant (28) . It may also be of interest to examine the effect of ATP on the physical properties of RAD50 protein.
Additional aspects of RAD50 function RAD50 protein probably works in concert with one or more additional proteins in vivo. The products of the MRE11 and XRS2 genes are obvious candidates, since rad50, mrell, and xrs2 mutants have virtually identical phenotypes (29, 30) . Purified Mrel 1 protein also exhibits DNA binding activity (K.Jozuka and H.Ogawa, personal communication).
The possibility that RAD50 protein is capable of additional and/or more complex activities remains to be investigated. An important component of RAD50 function may be its ability to recruit to its site of binding other proteins involved in DSB recombination, e.g. other members of the RAD50 series epistasis group. More speculatively, since the predicted length of extended coiled coil region for a pair of RAD50 proteins interacting along their lengths is about the distance between lateral elements of the synaptonemal complex, RAD50 protein might be localized to the SC (14) . The sequence of the protein does not provide any indication of a complex enzymatic activity; it resembles neither a helicase (31) nor a member of the emerging RecA family (32) (33) (34) (35) .
Models for the role of RAD50 function in vivo
Two general features of RAD50 function seem clear. First, RAD50 function acts at an early stage of recombination, both for DSB-promoted events in mitotic cells (3) and during meiotic recombination (reviewed in 5). In both situations RAD50 function acts prior to RAD52 function as shown by mutant phenotypes and/or epistasis analysis. Second, RAD50 function is absolutely required for meiotic recombination (reviewed in 5) but is less essential for mitotic DSB-promoted recombinational repair. This latter point is shown by the fact that rad50 mutants are only partially defective in HO-mediated recombination in non-MAT sequences (3), in HO switching at MAT (A.McKee and N.K. unpublished results), and in zygotic lethality induced by irradiation of a donor strain prior to conjugation with an unirradiated recipient strain (J.Nitiss, personal communication). Most strikingly, a radSO null mutant is fully proficient for integration of linear DN A fragments introduced by transformation (E.A. and N.K. unpublished results cited in 5). These genetic observations are most simply explained if RAD50 protein participates directly in DSB repair and meiotic chromosome metabolism (rather than acting solely as a transcription factor, for example) and we will assume that this is the case in the discussion that follows.
We have previously suggested that RADSO is defective in a genome-wide homology search that is required both for recombinational repair of DSBs in mitosis and during meiosis for recombination and chromosome pairing (5) . The relatively modest defects of radSO mutants in mitotic recombinational repair made it seem unlikely that RAD50 protein is the primary 'homology search' enzyme itself. We proposed instead that RAD50 protein might facilitate a homology search by stripping off inhibitory 'chromatin' proteins or by changing the topological state of the DNA (5). This proposal was based on the fact that RAD50 acts early in recombination, on the notion (6) that meiotic recombination might normally be under negative control by virtue of 'chromatin structure', and the finding that radSO mutants exhibit no discernible defect in integration of (naked) linear transforming DNA but are significantly defective in DSB repair when breaks are induced endogenously. In addition, we suggested, RAD50 protein might help recruit other proteins to the site of a recombination event.
Upon further reflection, we find it especially intriguing that RAD50 protein must act after the occurrence of DSBs in mitotic cells but before the occurrence of DSBs during meiosis. This difference could easily account for the stronger defect of radSO mutants in meiosis as opposed to mitosis since RAD50 function is required for occurrence of a crucial initial event (the DSB) in the former case but not the latter. When we considered this paradox in light of the possibility that RAD50 protein might alter chromatin structure, we were led to the general proposal that there is something similar about the sites where DSBs are destined to occur in meiotic chromatin and the sites of endogenous DSBs in mitotic cells, and that RAD50 protein recognizes this crucially similar feature. In this case, we could refine our original model to suggest that RAD50 protein first recognizes the appropriate chromatin feature and then acts to convert the DNA at this site into a form that 'reveals the nucleic acid to the recombination machinery' (5) and is appropriate for later steps in the recombination pathway.
It is now possible to speculate specifically about the nature of such a feature in light of the recent provocative observation of a 1:1 correspondence between DNase hypersensitive sites in mitotic chromatin and sites at which DSBs occur in meiosis (T.-C.Wu and Michael Lichten, manuscript in preparation). Since DNase hypersensitive sites are usually presumed to be places where nucleosome octamers are absent (either due to absence or disassociation of nucleosomal proteins), an economical hypothesis would be that nucleosomes undergo an analogous dissociation or disappearance spontaneously in the immediate vicinity of a DSB, and that RAD50 protein binds to such regions in both situations.
What then would RAD50 do upon binding to an appropriate chromatin feature? We originally suggested that RAD50 might strip away inhibitory proteins. In light of the finding that DSBs occur at places in the DNA that are already sensitive, it is possible to imagine that RAD50 serves simply as a recruiting agent, nucleating interactions amongst other proteins without necessarily altering the structure of DNA any further. However, we still favor the notion that RAD50 directly affects DNA structure as we originally proposed, for several reasons:
(1) The strongest argument to this effect is the simple fact that RAD50 function (and other gene products) is (are) required for occurrence of meiosis-specific DSBs. Recent observations suggest that these DSBs are probably made by a non-specific nuclease which cleaves at preferred positions throughout a lOObp region (L.Xu and N.K. manuscript in preparation). RAD50 (et al.) must either further alter 'chromatin structure' at the site of the break to permit formation of these DSBs and/or alter expression of a DSB nuclease, presumably also by affecting chromatin structure.
(2) A direct effect of RAD50 on chromatin structure is further supported by the fact that meiotic recombination within the rDNA of yeast is ft4D50-independent, but is instead dependent upon SIR2 function, which is now known to be a modulator of chromatin structure (36, 37, 38) .
The current observation that RAD50 binds DNA is certainly consistent with the notion that this protein affects chromatin or DNA structure. Furthermore, this observation makes it unlikely that the postulated effects of RAD50 on chromatin or DNA structure would be mediated solely by interactions with nucleosomes or other DNA-bound proteins; direct contact with the DNA should be involved. Also, our enthusiasm for the above model is increased by hints that binding of a single RAD50 molecule may nucleate loading on of additional molecules (15) ; such a process would be perfect for identification of a preferred DNA binding region by a single RAD50 molecule followed by enlargement of the susceptible region by binding of additional RAD50 molecules.
Once loaded onto DNA at an appropriate site, RAD50 protein might then play additional roles. Homology searching might occur in the context of the RAD50/DNA complex and/or additional proteins may be encouraged to bind to carry out subsequent steps.
Although the above discussion is very speculative, it provides a framework than can guide both in vivo and in vitro analysis in the future.
